Applicant, as named in the Orange Book

Mdd Us

Next listed expiry: Onapgo on 3 Feb 2028. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Onapgo NDA 214056 apomorphine hydrochloride	apomorphine hydrochloride	3 Feb 2028 exclusivity	exclusivity
Xadago NDA 207145 · 2 strengths safinamide mesylate	safinamide mesylate	21 Mar 2031 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Apokyn NDA 021264 apomorphine hydrochloride	apomorphine hydrochloride	open now no listed protection	no listed protection